Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jason Lamar is active.

Publication


Featured researches published by Jason Lamar.


Bioorganic & Medicinal Chemistry Letters | 2003

Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors

Shu-Hui Chen; Jason Lamar; Frantz Victor; Nancy June Snyder; Robert B. Johnson; Beverly A. Heinz; Mark Wakulchik; Q.May Wang

Abstract We describe herein the synthesis and biological evaluation of a series of tripeptidyl α-ketoamides as human rhinovirus (HRV) 3C protease inhibitors. The most potent inhibitor discussed in this manuscript, 4I, exhibited impressive enzyme inhibitory activity as well as antiviral activity against HRV-14.


Journal of Medicinal Chemistry | 2016

Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase

Michael J. Genin; Isabel C. Gonzalez Valcarcel; William Glen Holloway; Jason Lamar; Marian Mosior; Eric Hawkins; Thomas Estridge; Jeffrey Weidner; Thomas W. Seng; David Yurek; Lisa A. Adams; Jennifer Weller; Vincent L. Reynolds; Joseph T. Brozinick

To develop novel treatments for type 2 diabetes and dyslipidemia, we pursued inhibitors of serine palmitoyl transferase (SPT). To this end compounds 1 and 2 were developed as potent SPT inhibitors in vitro. 1 and 2 reduce plasma ceramides in rodents, have a slight trend toward enhanced insulin sensitization in DIO mice, and reduce triglycerides and raise HDL in cholesterol/cholic acid fed rats. Unfortunately these molecules cause a gastric enteropathy after chronic dosing in rats.


Bioorganic & Medicinal Chemistry Letters | 2004

Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor

Yvonne Yip; Frantz Victor; Jason Lamar; Robert B. Johnson; Q.May Wang; Donna Barket; John Irvin Glass; Ling Jin; Lifei Liu; Daryl Venable; Mark Wakulchik; Congping Xie; Beverly A. Heinz; Elcira C. Villarreal; Joe Colacino; Nathan Yumibe; Mark Joseph Tebbe; John E. Munroe; Shu-Hui Chen


Bioorganic & Medicinal Chemistry Letters | 2004

P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors

Yvonne Yip; Frantz Victor; Jason Lamar; Robert B. Johnson; Q.May Wang; John Irvin Glass; Nathan Yumibe; Mark Wakulchik; John E. Munroe; Shu-Hui Chen


Bioorganic & Medicinal Chemistry Letters | 2004

P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors

Frantz Victor; Jason Lamar; Nancy June Snyder; Yvonne Yip; Deqi Guo; Nathan Yumibe; Robert B. Johnson; Q.May Wang; John Irvin Glass; Shu-Hui Chen


Journal of Medicinal Chemistry | 2006

Design and synthesis of dual peroxisome proliferator-activated receptors γ and δ agonists as novel euglycemic agents with a reduced weight gain profile

Yanping Xu; Garret J. Etgen; Carol L. Broderick; Emily J. Canada; Isabel C. Gonzalez; Jason Lamar; Chahrzad Montrose-Rafizadeh; Brian A. Oldham; John Osborne; Chaoyu Xie; Qing Shi; Leonard L. Winneroski; Jeremy Schulenburg York; Nathan Yumibe; Richard W. Zink; Nathan Bryan Mantlo


Bioorganic & Medicinal Chemistry Letters | 2004

Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR

Jason Lamar; Jingdan Hu; Ana B. Bueno; Hsiu-Chiung Yang; Deqi Guo; James Densmore Copp; James McGee; Bruce D. Gitter; David E. Timm; Patrick C. May; James R. McCarthy; Shu-Hui Chen


Bioorganic & Medicinal Chemistry Letters | 2004

Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitors

Jason Lamar; Frantz Victor; Nancy June Snyder; Robert B. Johnson; Q.May Wang; John Irvin Glass; Shu-Hui Chen


Bioorganic & Medicinal Chemistry Letters | 2007

Design and synthesis of a novel class of dual PPARγ/δ agonists

Isabel C. Gonzalez; Jason Lamar; Fatima Iradier; Yanping Xu; Leonard L. Winneroski; Jeremy Schulenburg York; Nathan Yumibe; Richard W. Zink; Chahrzad Montrose-Rafizadeh; Gary J. Etgen; Carol L. Broderick; Brian A. Oldham; Nathan Bryan Mantlo


Letters in Drug Design & Discovery | 2005

P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors

Shu-Hui Chen; Jason Lamar; Yvonne Yip; Frantz Victor; Robert B. Johnson; Q.May Wang; John Irvin Glass; Beverly A. Heinz; Joseph M. Colacino; Deqi Guo; Mark Joseph Tebbe; John E. Munroe

Collaboration


Dive into the Jason Lamar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ling Jin

Eli Lilly and Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xicheng Sun

Vertex Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge